Home › Funds › Atlas Venture Life Science Advisors, LLC › KRRO
Atlas Venture Life Science Advisors, LLC position in KRRO
KORRO BIO INC · Health Care
Atlas Venture Life Science Advisors, LLC reported holding 773,260 shares of KRRO (KORRO BIO INC) in its Q3 2026 13F filing — a position valued at US$7.7M, representing 1.21% of its reported portfolio and ranking #8 among its reported holdings. Atlas Venture Life Science Advisors, LLC has disclosed KRRO holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Atlas Venture Life Science Advisors, LLC's KRRO position evolved
Atlas Venture Life Science Advisors, LLC first disclosed a stake in KRRO in Q4 2023 at 1,119,292 shares (US$53.6M). The position peaked in Q1 2024 at 1,119,292 shares, worth US$100.7M. Across 12 filings, Atlas Venture Life Science Advisors, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 773,260 shares valued at US$7.7M — a reduction of -189,624 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 1.12M | $53.65M | New |
| Q1 2024 | 1.12M | $100.74M | Hold |
| Q2 2024 | 1.14M | $38.52M | Add |
| Q3 2024 | 1.14M | $38.00M | Hold |
| Q4 2024 | 1.14M | $43.29M | Hold |
| Q1 2025 | 1.14M | $19.80M | Hold |
| Q2 2025 | 1.14M | $14.20M | Hold |
| Q3 2025 | 1.14M | $54.46M | Hold |
| Q4 2025 | 1.14M | $9.11M | Hold |
| Q1 2026 | 1.14M | $12.87M | Hold |
| Q2 2026 | 962.88K | $12.69M | Reduce |
| Q3 2026 | 773.26K | $7.66M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KRRO and 13F data
KRRO (KORRO BIO INC) is a Health Care company. 32 other funds we track also report a position in KRRO — the largest reported positions include Lynx1 Capital Management LP (US$20.3M), NEA Management Company, LLC (US$17.1M), Venrock Adviser, LLC (US$13.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KRRO
- Lynx1 Capital Management LP 1.54M sh · $20.27M · Q2 2026
- NEA Management Company, LLC 1.30M sh · $17.11M · Q2 2026
- Venrock Adviser, LLC 1.01M sh · $13.31M · Q2 2026
- TCG Crossover Management, LLC 416.30K sh · $5.49M · Q2 2026
- Kalehua Capital Management LLC 473.60K sh · $4.69M · Q3 2026
- 72 Investment Holdings, LLC 276.83K sh · $3.65M · Q2 2026
More on Atlas Venture Life Science Advisors, LLC
FAQ
How long has Atlas Venture Life Science Advisors, LLC held KRRO?
Atlas Venture Life Science Advisors, LLC has disclosed KRRO holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Atlas Venture Life Science Advisors, LLC's current position in KRRO?
As of Q3 2026, Atlas Venture Life Science Advisors, LLC holds 773.26K shares of KRRO (KORRO BIO INC), valued at $7.66M, representing 1.21% of its reported portfolio and ranking #8.
Has Atlas Venture Life Science Advisors, LLC been buying or selling KRRO?
In the latest 13F filing (Q3 2026), Atlas Venture Life Science Advisors, LLC reduced its position in KRRO. The position peaked in Q1 2024 at 1.12M shares.
Which other funds hold KRRO?
Other major institutional holders of KRRO include Lynx1 Capital Management LP, NEA Management Company, LLC, Venrock Adviser, LLC, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.